Approvals/TGA/HYQVIA - Normal Immunoglobulin Infusion 10% (Human) with Vorhyaluronidase alfa, Injection solution for subcutaneous use

Approved

STANDARD

HYQVIA - Normal Immunoglobulin Infusion 10% (Human) with Vorhyaluronidase alfa, Injection solution for subcutaneous use

Takeda Pharmaceuticals Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: f8e52a91dbd57b8d
Product Name: HYQVIA - Normal Immunoglobulin Infusion 10% (Human) with Vorhyaluronidase alfa, Injection solution for subcutaneous use
Artg Id: 235178
Artg Name: HYQVIA - Normal Immunoglobulin Infusion 10% (Human) with Vorhyaluronidase alfa, Injection solution for subcutaneous use
Sponsor: Takeda Pharmaceuticals Australia Pty Ltd
Company Detail Path: /organization/takeda-pharmaceuticals-australia-pty-ltd
Artg Date: 2016-04-27
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/0d25dd8dfcba65b2c994c0a33ad5cc76.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/ec329a65620f62c9279f9e7ca5bda167.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

f8e52a91dbd57b8d

Type

Standard